Skip to content

EMDR as an innovative strategy in the treatment of OCD

EMDR as an innovative strategy in the treatment of OCD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29117
Enrollment
10
Registered
2018-11-14
Start date
2017-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive disorders (OCD)

Interventions

There are weekly sessions. In the exploration phase 4 sessions of 45 minutes each are held for case conceptualisation and psycho-education. This is followed by the active treatment phase with a total
6 sessions (90 min.) EMDR
15 sessions (90 min) Exposure and Respons Prevention (ERP)

Sponsors

Department of Clinical Psychology, Utrecht University, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients are eligible when: a) they meet sufficient criteria for OCD, as established with the Structured Clinical Interview for DSM-IV disorders, and b) their total score on the YBOCS is over 15 (moderate to severe OCD symptoms).

Exclusion criteria

Exclusion criteria: Patients are excluded when: a) they already received ERP or EMDR less than 1 year ago, or b) they suffer from psychotic disorders, substance abuse/addiction, or a severe depression (score on Beck Depression Inventory-II >30), or c) insufficient knowledge of the Dutch language, or d) mental retardation (IQ<80). The use of anti-depressants is permitted, provided that dosages are kept constant during the study, and usage has started at least 3 months before entering the trial.

Design outcomes

Primary

MeasureTime frame
YBOCS (every week from baseline to return-to-baseline; also at 6 months FU)

Secondary

MeasureTime frame
SCID-I, OCI-R, OBQ-44, BDI-II, WHOQOL-BREF (baseline, after treatment, 6 months FU); WHOQOL-BREF (also last session EMDR); VASs (last session of a) exploration phase, and b) EMDR); Actual drop-out.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)